By BY REBECCA ROBBINS from NYT The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.Science https://ift.tt/3cRWljD
via
Merck says its antiviral pill is less effective in a final analysis.
By BY REBECCA ROBBINS from NYT The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.Science https://ift.tt/3cRWljD
via
0 comments:
Post a Comment